• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酵母双杂交分析用于筛选人类去泛素化酶的泛素变体抑制剂。

Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases.

机构信息

Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3E1, Canada; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada.

Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada.

出版信息

J Mol Biol. 2019 Mar 15;431(6):1160-1171. doi: 10.1016/j.jmb.2019.02.007. Epub 2019 Feb 11.

DOI:10.1016/j.jmb.2019.02.007
PMID:30763569
Abstract

We applied a yeast-two-hybrid (Y2H) analysis to screen for ubiquitin variant (UbV) inhibitors of a human deubiquitinase (DUB), ubiquitin-specific protease 2 (USP2). The Y2H screen used USP2 as the bait and a prey library consisting of UbVs randomized at four specific positions, which were known to interact with USP2 from phage display analysis. The screen yielded numerous UbVs that bound to USP2 both as a Y2H interaction in vivo and as purified proteins in vitro. The Y2H-derived UbVs inhibited the catalytic activity of USP2 in vitro with nanomolar-range potencies, and they bound and inhibited USP2 in human cells. Mutational and structural analysis showed that potent and selective inhibition could be achieved by just two substitutions in a UbV, which exhibited improved hydrophobic and hydrophilic contacts compared to the wild-type ubiquitin interaction with USP2. Our results establish Y2H as an effective platform for the development of UbV inhibitors of DUBs in vivo, providing an alternative strategy for the analysis of DUBs that are recalcitrant to phage display and other in vitro methods.

摘要

我们应用酵母双杂交(Y2H)分析筛选了人泛素特异性蛋白酶 2(USP2)的泛素变体(UbV)抑制剂。Y2H 筛选以 USP2 为诱饵,以由四个特定位置随机化的 UbV 组成的前体文库为诱饵,这些位置是从噬菌体展示分析中已知与 USP2 相互作用的。筛选产生了许多 UbV,它们既可以在体内作为 Y2H 相互作用,也可以作为体外纯化蛋白与 USP2 结合。Y2H 衍生的 UbV 以纳摩尔范围的效力在体外抑制 USP2 的催化活性,并且它们在人细胞中结合并抑制 USP2。突变和结构分析表明,UbV 中的两个取代即可实现有效且选择性的抑制,与野生型泛素与 USP2 的相互作用相比,UbV 显示出改善的疏水性和亲水性接触。我们的结果确立了 Y2H 作为体内 DUBs 的 UbV 抑制剂开发的有效平台,为分析对噬菌体展示和其他体外方法有抗性的 DUBs 提供了另一种策略。

相似文献

1
Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases.酵母双杂交分析用于筛选人类去泛素化酶的泛素变体抑制剂。
J Mol Biol. 2019 Mar 15;431(6):1160-1171. doi: 10.1016/j.jmb.2019.02.007. Epub 2019 Feb 11.
2
Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1.结构和功能表征泛素变体抑制剂对 JAMM 家族去泛素化酶 STAMBP 和 STAMBPL1。
J Biol Chem. 2021 Oct;297(4):101107. doi: 10.1016/j.jbc.2021.101107. Epub 2021 Aug 21.
3
Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases.开发具有泛素 C 端水解酶去泛素化酶选择性的泛素变体。
Biochemistry. 2020 Sep 22;59(37):3447-3462. doi: 10.1021/acs.biochem.9b01076. Epub 2020 Sep 8.
4
Saturation scanning of ubiquitin variants reveals a common hot spot for binding to USP2 and USP21.泛素变体的饱和度扫描揭示了与USP2和USP21结合的一个共同热点。
Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8705-10. doi: 10.1073/pnas.1524648113. Epub 2016 Jul 19.
5
Targeting Deubiquitinases in Cancer.靶向癌症中的去泛素化酶
Methods Mol Biol. 2018;1731:295-305. doi: 10.1007/978-1-4939-7595-2_25.
6
Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.USP7和USP10细胞内泛素变体抑制剂的生成与验证
J Mol Biol. 2017 Nov 10;429(22):3546-3560. doi: 10.1016/j.jmb.2017.05.025. Epub 2017 Jun 3.
7
Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.蛋白酶体相关半胱氨酸去泛素化酶是环境光增白剂化合物的分子靶标。
J Cell Biochem. 2019 Aug;120(8):14065-14075. doi: 10.1002/jcb.28682. Epub 2019 Apr 8.
8
Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells.异硫氰酸酯作为人癌细胞蛋白酶体半胱氨酸脱泛素酶抑制剂的计算和生化研究。
J Cell Biochem. 2018 Nov;119(11):9006-9016. doi: 10.1002/jcb.27157. Epub 2018 Jul 17.
9
On the Study of Deubiquitinases: Using the Right Tools for the Job.泛素化酶的研究:正确的工具做正确的事。
Biomolecules. 2022 May 14;12(5):703. doi: 10.3390/biom12050703.
10
Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.工程化泛素变体对致病性病毒的强效和选择性抑制作用。
PLoS Pathog. 2017 May 18;13(5):e1006372. doi: 10.1371/journal.ppat.1006372. eCollection 2017 May.

引用本文的文献

1
Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy.靶向泛素-蛋白酶体系统与癌症治疗的最新进展。
Cells. 2023 Dec 22;13(1):29. doi: 10.3390/cells13010029.
2
Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies.泛素工程用于探究泛素蛋白酶体系统和新型治疗策略。
Cells. 2023 Aug 21;12(16):2117. doi: 10.3390/cells12162117.
3
Cryo-EM reveals a mechanism of USP1 inhibition through a cryptic binding site.冷冻电镜揭示了通过一个隐蔽结合位点抑制USP1的机制。
Sci Adv. 2022 Sep 30;8(39):eabq6353. doi: 10.1126/sciadv.abq6353. Epub 2022 Sep 28.
4
Emerging drug development technologies targeting ubiquitination for cancer therapeutics.新兴的药物研发技术针对泛素化作用治疗癌症。
Pharmacol Ther. 2019 Jul;199:139-154. doi: 10.1016/j.pharmthera.2019.03.003. Epub 2019 Mar 7.